BCLI

BrainStorm Cell Therapeutics In

BCLI·10501E201·US·Common Stock·Healthcare - Biotechnology-13D/G

BCLI (BrainStorm Cell Therapeutics In) is held by 2 institutional investors as of Q3 2025. Largest holders: OSAIC HOLDINGS, INC. ($1,351), Steward Partners Investment Advisory, LLC ($80). Net institutional sentiment: Bearish.

2
Holders
Avg rating(5 Elite)
$1,431
Total Value
0% (16)
Fund Consensus
0 buying - 14 selling

No verdict yet — fewer than 2 funds hold BCLI.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
1,785$1,3510.0%-99.18%
0
Unchanged
113$800.0%-98.49%
0
Exited
0(-100.0%)$6,4990.0%-81.22%
0
Exited
0(-100.0%)$13,8650.0%-51.67%
0
Exited
0(-100.0%)$28,1930.0%-70.46%
0
Exited
0(-100.0%)$61,1430.0%-98.28%
0
Exited
0(-100.0%)$1,4990.0%-77.68%
0
Exited
0(-100.0%)$110.0%-86.27%
0
Exited
0(-100.0%)$7430.0%-33.96%
0
Exited
0(-100.0%)$2290.0%-41.18%
0
Exited
0(-100.0%)$270.0%-70.46%
0
Exited
0(-100.0%)$31,0510.0%-78.79%
0
Exited
0(-100.0%)$70.0%-60.05%
0
Exited
0(-100.0%)$1520.0%-66.44%
0
Exited
0(-100.0%)$5,7770.0%-33.96%
0
Exited
0(-100.0%)$11,9820.0%-33.96%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used